,NR 607 Midterm Exam – Diagnosis & Management in
PMHNP III – Q&A (2026) PDF | Chamberlain
1. A PMHNP is conducting a comprehensive psychiatric assessment. Which of the following is
a core component?
A) History, mental status examination, physical examination, and diagnostic tests
B) History, genogram, physical examination, and laboratory tests
C) Mental status examination, psychosocial assessment, family history, and diagnostic tests
D) History, mental status examination, family history, and diagnostic tests
Correct Answer: A) History, mental status examination, physical examination, and diagnostic
tests
Rationale: A comprehensive psychiatric assessment includes a thorough history, mental
status exam, physical exam, and indicated diagnostic tests. Psychosocial and family history
are part of the history component, not separate core elements. This approach ensures a
biopsychosocial understanding.
2. The primary goal of inpatient psychiatric treatment is:
A) Complete resolution of all psychiatric symptoms
B) Crisis stabilization and safety
C) Long-term psychosocial rehabilitation
D) Medication optimization only
Correct Answer: B) Crisis stabilization and safety
Rationale: Inpatient psychiatric care focuses on acute crisis intervention, ensuring patient
safety, and stabilizing severe symptoms. Long-term rehabilitation and complete symptom
resolution are typically addressed in outpatient settings. The emphasis is on immediate risk
reduction.
,3. Informed consent in psychiatric practice is a fundamental ethical and legal principle that
respects the client's:
A) Right to refuse all treatment
B) Autonomy in medical decision-making
C) Right to have family make decisions
D) Right to receive treatment without questions
Correct Answer: B) Autonomy in medical decision-making
Rationale: Informed consent upholds the client's right to self-determination. The client must
receive adequate information about risks, benefits, and alternatives, and can ask questions.
This process is essential for ethical practice, even when the client has a mental illness.
4. A PMHNP speaks at a community meeting advocating for expansion of mental health
services. This action best demonstrates which ethical principle?
A) Advocacy for the Healthcare Consumer
B) Collaboration to Meet Health Needs
C) Promotion of the Nursing Profession
D) Advancement of the Nursing Profession
Correct Answer: C) Promotion of the Nursing Profession
Rationale: The PMHNP participates in policy development to ensure mental health care is
accessible and delivered with respect. This is an example of Promotion of the Nursing
Profession, distinct from individual patient advocacy. It advances the role of nursing in
society.
5. The tendency to attribute another person's behavior to their personality rather than
situational factors is known as:
, A) Perceptual salience
B) Fundamental attribution error
C) Two-step attribution process
D) Confirmation bias
Correct Answer: B) Fundamental attribution error
Rationale: Fundamental attribution error is the bias to overestimate dispositional factors and
underestimate situational influences when explaining others' behavior. Perceptual salience
refers to the focus of attention; two-step process involves initial internal attribution then
adjustment.
6. The PMHNP is reviewing the concept of bioavailability. Which statement best defines it?
A) The time it takes for a drug to reach peak plasma concentration
B) The portion of a dose that reaches systemic circulation and is available to act on body cells
C) The rate at which a drug is excreted by the kidneys
D) The strength of binding between a drug and its receptor
Correct Answer: B) The portion of a dose that reaches systemic circulation and is available to
act on body cells
Rationale: Bioavailability describes the fraction of an administered drug that reaches systemic
circulation unchanged. It is influenced by absorption and first-pass metabolism. It is not
about peak time, excretion rate, or receptor affinity.
7. A PMHNP prescribes a medication that is an agonist at mu-opioid receptors. This means
the drug:
A) Blocks the receptor and prevents activation
B) Binds to the receptor and produces a biologic response
PMHNP III – Q&A (2026) PDF | Chamberlain
1. A PMHNP is conducting a comprehensive psychiatric assessment. Which of the following is
a core component?
A) History, mental status examination, physical examination, and diagnostic tests
B) History, genogram, physical examination, and laboratory tests
C) Mental status examination, psychosocial assessment, family history, and diagnostic tests
D) History, mental status examination, family history, and diagnostic tests
Correct Answer: A) History, mental status examination, physical examination, and diagnostic
tests
Rationale: A comprehensive psychiatric assessment includes a thorough history, mental
status exam, physical exam, and indicated diagnostic tests. Psychosocial and family history
are part of the history component, not separate core elements. This approach ensures a
biopsychosocial understanding.
2. The primary goal of inpatient psychiatric treatment is:
A) Complete resolution of all psychiatric symptoms
B) Crisis stabilization and safety
C) Long-term psychosocial rehabilitation
D) Medication optimization only
Correct Answer: B) Crisis stabilization and safety
Rationale: Inpatient psychiatric care focuses on acute crisis intervention, ensuring patient
safety, and stabilizing severe symptoms. Long-term rehabilitation and complete symptom
resolution are typically addressed in outpatient settings. The emphasis is on immediate risk
reduction.
,3. Informed consent in psychiatric practice is a fundamental ethical and legal principle that
respects the client's:
A) Right to refuse all treatment
B) Autonomy in medical decision-making
C) Right to have family make decisions
D) Right to receive treatment without questions
Correct Answer: B) Autonomy in medical decision-making
Rationale: Informed consent upholds the client's right to self-determination. The client must
receive adequate information about risks, benefits, and alternatives, and can ask questions.
This process is essential for ethical practice, even when the client has a mental illness.
4. A PMHNP speaks at a community meeting advocating for expansion of mental health
services. This action best demonstrates which ethical principle?
A) Advocacy for the Healthcare Consumer
B) Collaboration to Meet Health Needs
C) Promotion of the Nursing Profession
D) Advancement of the Nursing Profession
Correct Answer: C) Promotion of the Nursing Profession
Rationale: The PMHNP participates in policy development to ensure mental health care is
accessible and delivered with respect. This is an example of Promotion of the Nursing
Profession, distinct from individual patient advocacy. It advances the role of nursing in
society.
5. The tendency to attribute another person's behavior to their personality rather than
situational factors is known as:
, A) Perceptual salience
B) Fundamental attribution error
C) Two-step attribution process
D) Confirmation bias
Correct Answer: B) Fundamental attribution error
Rationale: Fundamental attribution error is the bias to overestimate dispositional factors and
underestimate situational influences when explaining others' behavior. Perceptual salience
refers to the focus of attention; two-step process involves initial internal attribution then
adjustment.
6. The PMHNP is reviewing the concept of bioavailability. Which statement best defines it?
A) The time it takes for a drug to reach peak plasma concentration
B) The portion of a dose that reaches systemic circulation and is available to act on body cells
C) The rate at which a drug is excreted by the kidneys
D) The strength of binding between a drug and its receptor
Correct Answer: B) The portion of a dose that reaches systemic circulation and is available to
act on body cells
Rationale: Bioavailability describes the fraction of an administered drug that reaches systemic
circulation unchanged. It is influenced by absorption and first-pass metabolism. It is not
about peak time, excretion rate, or receptor affinity.
7. A PMHNP prescribes a medication that is an agonist at mu-opioid receptors. This means
the drug:
A) Blocks the receptor and prevents activation
B) Binds to the receptor and produces a biologic response
